WallStreetZenWallStreetZen

NYSE: CNMD
Conmed Corp Stock

$71.65+0.90 (+1.27%)
Updated May 7, 2024
CNMD Price
$71.65
Fair Value Price
N/A
Market Cap
$2.21B
52 Week Low
$61.05
52 Week High
$138.47
P/E
26.64x
P/B
2.58x
P/S
1.95x
PEG
0.59x
Dividend Yield
1.12%
Revenue
$1.26B
Earnings
$82.35M
Gross Margin
54.9%
Operating Margin
11.33%
Profit Margin
6.5%
Debt to Equity
1.7
Operating Cash Flow
$158M
Beta
1.28
Next Earnings
May 23, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CNMD Overview

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CNMD scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CNMD ($71.65) is trading above its intrinsic value of $57.43, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CNMD is good value based on its earnings relative to its share price (26.64x), compared to the US market average (32.4x)
P/E vs Market Valuation
CNMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CNMD due diligence checks available for Premium users.

Be the first to know about important CNMD news, forecast changes, insider trades & much more!

CNMD News

Valuation

CNMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
26.64x
Industry
27.36x
Market
32.4x
CNMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CNMD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CNMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.58x
Industry
3.73x
CNMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CNMD price to earnings growth (PEG)

For valuing profitable companies with growth potential
CNMD is good value based... subscribe to Premium to read more.
PEG Value Valuation

CNMD's financial health

Profit margin

Revenue
$312.3M
Net Income
$19.7M
Profit Margin
6.3%
CNMD's Earnings (EBIT) of $142.92M... subscribe to Premium to read more.
Interest Coverage Financials
CNMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.3B
Liabilities
$1.5B
Debt to equity
1.7
CNMD's short-term assets ($635.72M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CNMD's long-term liabilities ($1.16B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CNMD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CNMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$29.1M
Investing
-$2.0M
Financing
-$17.0M
CNMD's operating cash flow ($158.32M)... subscribe to Premium to read more.
Debt Coverage Financials

CNMD vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
CNMD$2.21B+1.27%26.64x2.58x
RXST$2.31B-1.03%-49.75x14.11x
IART$1.98B+8.38%49.18x1.24x
UFPT$1.93B-1.35%42.96x6.76x
NARI$2.49B+2.32%-107.03x5.57x

Conmed Stock FAQ

What is Conmed's quote symbol?

(NYSE: CNMD) Conmed trades on the NYSE under the ticker symbol CNMD. Conmed stock quotes can also be displayed as NYSE: CNMD.

If you're new to stock investing, here's how to buy Conmed stock.

What is the 52 week high and low for Conmed (NYSE: CNMD)?

(NYSE: CNMD) Conmed's 52-week high was $138.47, and its 52-week low was $61.05. It is currently -48.26% from its 52-week high and 17.36% from its 52-week low.

How much is Conmed stock worth today?

(NYSE: CNMD) Conmed currently has 30,800,747 outstanding shares. With Conmed stock trading at $71.65 per share, the total value of Conmed stock (market capitalization) is $2.21B.

Conmed stock was originally listed at a price of $17.50 in Dec 31, 1997. If you had invested in Conmed stock at $17.50, your return over the last 26 years would have been 309.43%, for an annualized return of 5.57% (not including any dividends or dividend reinvestments).

How much is Conmed's stock price per share?

(NYSE: CNMD) Conmed stock price per share is $71.65 today (as of May 7, 2024).

What is Conmed's Market Cap?

(NYSE: CNMD) Conmed's market cap is $2.21B, as of May 8, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Conmed's market cap is calculated by multiplying CNMD's current stock price of $71.65 by CNMD's total outstanding shares of 30,800,747.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.